Reaction
Rotator Cuff Repair reporting signals
As of the last recalculation, Rotator Cuff Repair appears in 1,711 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 49.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Methylprednisolone Acetate | 32 | 49.5 | 49.7 |
| Diclofenac Potassium, Film Coated | 18 | 26.3 | 26.3 |
| Diclofenac Potassium Tablets | 18 | 26.3 | 26.3 |
| Diclofenac Potassium | 21 | 23.9 | 24.0 |
| Alendronate Sodium | 133 | 17.3 | 17.3 |
| Upadacitinib | 82 | 12.8 | 12.8 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 8 | 11.3 | 11.4 |
| Risankizumab-Rzaa | 70 | 10.8 | 10.8 |
| Sodium Oxybate | 50 | 9.5 | 9.5 |
| Sulfasalazine | 52 | 8.3 | 8.3 |
| Tofacitinib | 91 | 6.3 | 6.3 |
| Armodafinil | 10 | 5.8 | 5.8 |
| Icosapent Ethyl | 4 | 5.7 | 5.7 |
| Eptinezumab-Jjmr | 4 | 5.4 | 5.4 |
| Fluticasone Propionate And Salmeterol | 17 | 5.0 | 5.0 |
| Etanercept | 190 | 4.2 | 4.2 |
| Exenatide | 18 | 4.2 | 4.2 |
| Oxymorphone Hydrochloride | 4 | 4.2 | 4.2 |
| Bimekizumab | 7 | 4.0 | 4.0 |
| Teriflunomide | 13 | 3.5 | 3.5 |
| Dupilumab | 64 | 1.6 | 1.6 |
| Valbenazine | 3 | 1.5 | 1.5 |